Suraksha Diagnostic Share Price Forecast to 2030

The Suraksha Diagnostic share price forecast for the next 3 years is a question on many investors' minds as the stock trades at Rs 247.10, within a 52 week range of Rs 224.00 to Rs 334.00. This article lays out a scenario based Suraksha Diagnostic share price outlook for 2027, 2028 and 2030, built on the company's fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Suraksha Diagnostic Company Overview

Suraksha Diagnostic operates a chain of diagnostic centres and pathology laboratories in West Bengal and Eastern India, having listed in 2024. Understanding the business model is the first step in framing any credible Suraksha Diagnostic share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Suraksha Diagnostic
NSE Ticker	SURAKSHA
CMP	Rs 247.10
52 Week High	Rs 334.00
52 Week Low	Rs 224.00
Market Cap	Rs 1287. Cr
Stock PE	40.0
Book Value	₹ 47.0
ROE	14.1 %
ROCE	17.0 %
Dividend Yield	0.20 %

Where Does Suraksha Diagnostic Share Price Stand Today?

The stock currently trades at Rs 247.10, within a 52 week range of Rs 224.00 to Rs 334.00. For anyone building a Suraksha Diagnostic share price forecast, this means the valuation starting point is a P/E of 40.0. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

At the current price, Suraksha Diagnostic commands a market capitalisation of Rs 1287. Cr and trades at a price to earnings multiple of 40.0. The company generates a return on equity of 14.1 % and a return on capital employed of 17.0 %. These numbers anchor the Suraksha Diagnostic share price forecast scenarios that follow.

Suraksha Diagnostic Share Price Forecast: Key Growth Drivers for the Next 3 Years

The primary growth catalyst for Suraksha Diagnostic is rising demand for organised diagnostics in Eastern India and network expansion. This driver is anchored in structural trends within the Healthcare sector.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. The pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Suraksha Diagnostic share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Healthcare Sector Dynamics

Sector trends are a second key driver. Within the space, investors often benchmark Suraksha Diagnostic against peers such as Park Medi World, Jeena Sikho Lifecare, Lotus Eye Hospital and Institute on growth and valuations before forming a view on the Suraksha Diagnostic share price forecast for the next 3 years.

Balance Sheet and Debt Management

the ability to manage financial leverage will directly influence the Suraksha Diagnostic share price forecast. Companies that reduce debt or fund growth without diluting equity tend to see stronger share price appreciation.

Macro and Policy Environment

Interest rate cycles, currency movements and sector-specific policy changes will also shape the Suraksha Diagnostic share price forecast over the 2027 to 2030 horizon. These are harder to predict but need to be monitored closely.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Key Risks to the Suraksha Diagnostic Share Price Forecast

The Suraksha Diagnostic share price forecast could be materially impacted by the company is newly listed with a shorter standalone track record, and competitive intensity in diagnostics from national chains is high. These risks are not unique to Suraksha Diagnostic but the degree of impact depends on the company's specific exposure and management quality.

Suraksha Diagnostic Share Price Forecast: 3-Year Scenario Table

The following indicative scenario analysis is illustrative only and does not constitute a research-grade price target. Actual outcomes will depend on company performance, sector dynamics, and macroeconomic conditions.

Scenario	3-Year Indicative Range	Key Assumptions
Bull Case	Rs 444.78	Strong execution, sector tailwinds materialise, margin expansion via operating leverage
Base Case	Rs 333.59	Steady growth broadly in line with sector, manageable cost pressures, stable demand conditions
Bear Case	Rs 185.32	Demand slowdown, margin compression from rising costs, or sector-specific headwinds materialise

These ranges are not investment advice. The bull case assumes key growth drivers materialise fully, while the bear case reflects meaningful headwinds. The base case represents a moderate, sector-average outcome.

Download the Univest iOS App or Univest Android App to track Suraksha Diagnostic share price and get real-time alerts.

Should You Invest in Suraksha Diagnostic?

Any investment in Suraksha Diagnostic must be evaluated against your own risk profile, investment horizon, and portfolio composition. The Suraksha Diagnostic share price forecast outlined here is scenario-based and not a guaranteed outcome. Key considerations are the growth drivers (rising demand for organised diagnostics in Eastern India and network expansion), the risks (the company is newly listed with a shorter standalone track record, and competit), and how those interact with your overall portfolio strategy.

Retail investors are always advised to consult a SEBI-registered investment advisor before taking any position. The Healthcare index provides a useful benchmark for comparing Suraksha Diagnostic share price performance against the broader sector.

Conclusion

The Suraksha Diagnostic share price forecast for the next 3 years ranges from Rs 185.32 in the bear case to Rs 444.78 in the bull case, with a base case around Rs 333.59. The primary driver is rising demand for organised diagnostics in Eastern India and network expansion, while the main risk is the company is newly listed with a shorter standalone track record, and competit. Investors should track quarterly results, balance sheet trends, and sector developments to refine their view as the forecast horizon approaches.

This article is for informational purposes only. Consult a SEBI-registered advisor before investing.

Frequently Asked Questions on Suraksha Diagnostic Share Price Forecast

What is the Suraksha Diagnostic share price forecast for the next 3 years?

Ans. The Suraksha Diagnostic share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 185.32 in the bear case to Rs 444.78 in the bull case, with a base case near Rs 333.59, depending on earnings delivery and market conditions.

What is the Suraksha Diagnostic share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 234.74 to Rs 321.23, with a base case around Rs 271.81. This assumes compounding on the current price of Rs 247.10 and is illustrative, not a guaranteed outcome.

What is the Suraksha Diagnostic share price forecast for 2028?

Ans. The 2028 scenario range is Rs 210.03 to Rs 370.65, with the base case near Rs 296.52. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Suraksha Diagnostic?

Ans. Suraksha Diagnostic currently trades at around Rs 247.10 on the NSE, within a 52 week range of Rs 224.00 to Rs 334.00. Prices change continuously during market hours, so check live quotes before acting.

Is Suraksha Diagnostic a good stock for the long term?

Ans. Suraksha Diagnostic has a long term story built on rising demand for organised diagnostics in Eastern India and network expansion, but it also carries risks since the company is newly listed with a shorter standalone track record, and competit. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Suraksha Diagnostic share price outlook for 2030?

Ans. The Suraksha Diagnostic share price outlook for 2030 spans Rs 185.32 to Rs 444.78 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Suraksha Diagnostic share price forecast?

Ans. The main risks are the company is newly listed with a shorter standalone track record, and competitive intensity in dia. Any of these can push the stock below the base case scenario discussed in this article.